CONTINUING MEDICAL EDUCATION

Accreditation

The Congress has applied for ESMO-MORA accreditation. Attendees will receive a certificate of attendance at the end of the Congress.

Who Should Attend

This Congress is specifically designed for practicing clinicians, gastroenterologists, hepatologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers who wish to review and update their knowledge and management of cancers of the gastrointestinal tract. Other healthcare professionals may also find this program beneficial.

Learning Objectives

• Identify current controversies in the management of patients with gastric or esophageal cancers
• Discuss contemporary treatment options for patients with gastric or esophageal cancers
• Comment on available treatment options for rare gastrointestinal and neuroendocrine tumors
• Recognize the epidemiology and pathogenesis of hepatocellular carcinoma
• Discuss management of patients with cancer of the liver
• Understand adjuvant and neoadjuvant treatment options for patients with locally advanced and metastatic cancer of the pancreas
• Select the most appropriate detection, screening and chemoprevention methods for colorectal cancer
• Generalize the use of molecular markers for screening and prognosis of colorectal cancer and gastric cancer
• Select the most appropriate adjuvant and neoadjuvant treatments for colorectal cancer patients
• Comment on new agents in the treatment of colorectal cancer and the latest clinical trials results
• Identify treatment strategies for rectal cancer
• Distinguish appropriate surgical techniques for the treatment of gastrointestinal cancers

Congress Secretariat
This Congress is developed and managed by

^©2009 Imedex^®, LLC. All rights reserved. Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.